Why Do We Get Alzheimer's Disease?
Multimedia
·
OSTI ID:1013682
- Stanford University
Neurodegenerative diseases and Alzheimer's disease (AD) in particular, are among the major health concerns of the elderly in industrialized societies. The cause of AD is unknown and no disease-modifying treatments are available. The disease is characterized clinically by a progressive dementia and pathologically by the accumulation of protein aggregates in the brain and a profound loss of nerve cells. It has also become clear recently that local immune responses are activated in the AD brain and may have a role in the disease. Our laboratory uses genetic mouse models to understand the disease process and to identify potential therapeutic targets.
- Research Organization:
- SLAC (SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States))
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1013682
- Resource Relation:
- Conference: SLAC Public Lecture Series, SLAC National Accelerator Laboratory, Menlo Park, California, presented on October 02, 2006
- Country of Publication:
- United States
- Language:
- English
Similar Records
Why do we get Alzheimer's disease?
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
Multimedia
·
Mon Oct 02 00:00:00 EDT 2006
·
OSTI ID:1013682
MicroRNAs as diagnostic and therapeutic tools for Alzheimer’s disease: advances and limitations
Journal Article
·
Tue Jan 01 00:00:00 EST 2019
· Neural Regeneration Research
·
OSTI ID:1013682
Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
Journal Article
·
Tue Jan 01 00:00:00 EST 2019
· Neural Regeneration Research
·
OSTI ID:1013682